Cost-Effectiveness of Cardioversion and Antiarrhythmic Therapy in Nonvalvular Atrial Fibrillation

  title={Cost-Effectiveness of Cardioversion and Antiarrhythmic Therapy in Nonvalvular Atrial Fibrillation},
  author={E. Catherwood and W. Fitzpatrick and Mark L. Greenberg and P. T. Holzberger and D. Malenka and B. Gerling and J. Birkmeyer},
  journal={Annals of Internal Medicine},
  • E. Catherwood, W. Fitzpatrick, +4 authors J. Birkmeyer
  • Published 1999
  • Medicine
  • Annals of Internal Medicine
  • The management of patients with nonvalvular atrial fibrillation requires that physicians assess the risks and benefits of two principal treatment options: antithrombotic therapy with control of the ventricular response or cardioversion to restore sinus rhythm. Because a series of large-scale, randomized trials demonstrated the efficacy of warfarin (1-6) or aspirin (5-8) in reducing the frequency of thromboembolic events, antithrombotic therapy plus rate control is considered the standard of… CONTINUE READING
    68 Citations

    Paper Mentions

    The purpose of this study is to determine if catheter-based atrial fibrillation (AF) ablation is superior to treatment with antiarrhythmic drugs as a first-line therapy for symptomatic… Expand
    ConditionsAtrial Fibrillation
    InterventionDrug, Procedure
    Antiarrhythmische Therapie von Vorhofflimmern
    • 1
    New insights into the mechanisms and management of atrial fibrillation.
    • P. Khairy, S. Nattel
    • Medicine
    • CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne
    • 2002
    • 52
    • PDF
    Cost Effectiveness of Therapies for Atrial Fibrillation
    • 8
    Atrial Fibrillation and Thromboembolism: A Decade of Progress in Stroke Prevention
    • 273
    Finding what you seek: analyzing therapies for nonvalvular atrial fibrillation.
    • 1
    • Highly Influenced
    Cost-Effectiveness of Rhythm versus Rate Control in Atrial Fibrillation
    • 88


    Low-dose amiodarone for atrial fibrillation.
    • 80
    Newer developments in the management of atrial fibrillation.
    • 101
    Amiodarone as a first-line drug in the treatment of atrial fibrillation: The protagonist viewpoint
    • S. Lévy
    • Medicine
    • Cardiovascular Drugs and Therapy
    • 2004
    • 7
    Risk of Initiating Antiarrhythmic Drug Therapy for Atrial Fibrillation in Patients Admitted to a University Hospital
    • 110
    Evolving strategies for the management of atrial fibrillation. The role of amiodarone.
    • 10
    Pilot study and protocol of the Canadian Trial of Atrial Fibrillation (CTAF).
    • 26
    Efficacy, safety, and determinants of conversion of atrial fibrillation and flutter with oral amiodarone.
    • 116
    • PDF
    Low-dose amiodarone for atrial fibrillation: time for a prospective study?
    • 54